Back to search

Article

Clonally-Expanded, Thyrotoxic Autoimmune Mediator CD8 <sup>+</sup> T cells Driven by IL21 Contribute to Checkpoint Inhibitor Thyroiditis

2022-12-19

Abstract excerpt

<h4>ABSTRACT</h4> Autoimmune toxicity occurs in up to 60% of patients treated with immune checkpoint inhibitor (ICI) cancer therapy and is an increasing clinical challenge with the expanding use of these treatments. To date, human immunopathogenic studies of immune related adverse events (IRAEs) have relied upon sampling of circulating peripheral blood cells rather than affected tissues. Here, we directly obtaine...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
599343e0-74e4-53ff-a700-3460444e7893
DOI
10.1101/2022.12.18.517398
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clonally-Expanded, Thyrotoxic Autoimmune Mediator CD8 <sup>+</sup> T cells Driven by IL21 Contribute to Checkpoint Inhibitor ThyroiditisDOI 10.1101/2022.12.18.517398
Select a neighboring publication to make it the new centre.